Mexico City, 10 April 2019 (PAHO)- Mexico has signed a declaration of intent to participate in the Pan American Health Organization’s (PAHO) Revolving and Strategic Funds, mechanisms that facilitate the joint purchase of vaccines, medicines and other quality medical products at competitive prices.
The declaration was signed at the National Palace by the Health Secretary of Mexico, Jorge Alcocer Varela, and the Director of PAHO, Carissa F. Etienne, within the framework of the regional celebration of World Health Day, and the presentation of the High-level Commission’s Report “Universal Health in the XXI Century: 40 years of Alma-Ata”.
Access to safe, quality and cost-effective medicines and technologies is an essential requirement for achieving universal health, which countries of the world have committed to reach by 2030.
The Revolving and Strategic funds consolidate country orders for the purchase of vaccines, syringes and supplies, in the case of the former, and for the purchase of essential medicines and strategic supplies in the case of the latter. They also ensure transparency in purchasing processes and are based on the principles of solidarity and Pan-Americanism.
Participation in international tenders with large-scale purchase volumes enables access to effective, high-quality products that comply with international safety standards, at lower prices.
Countries participating in these funds also Benefit from PAHO’s technical cooperation to plan demand and guarantee rational use and continuous supply.